Kingfisher Capital’s Bristol-Myers Squibb BMY Stock Holding History

Kingfisher Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,702	Closed	-$215K	–	168
2023 Q3	$215K	Sell	3,702 -31	-0.8%	-$1.9K	0.06%	150
2023 Q2	$239K	Buy	3,733 +149	+4%	+$9.99K	0.06%	152
2023 Q1	$248K	Buy	3,584 +2	+0.1%	+$141	0.07%	148
2022 Q4	$258K	Sell	3,582 -2,653	-43%	-$200K	0.07%	150
2022 Q3	$443K	Buy	+6,235	New	+$452K	0.12%	123
2016 Q4	–	Sell	-23,787	Closed	-$1.28M	–	122
2016 Q3	$1.28M	Sell	23,787 -1,043	-4%	-$67K	0.89%	52
2016 Q2	$1.83M	Sell	24,830 -1,297	-5%	-$91.6K	1.2%	29
2016 Q1	$1.67M	Sell	26,127 -24	-0.1%	-$1.51K	1.05%	36
2015 Q4	$1.8M	Buy	26,151 +1,879	+8%	+$124K	1.06%	29
2015 Q3	$1.44M	Sell	24,272 -96	-0.4%	-$6.09K	0.91%	43
2015 Q2	$1.62M	Sell	24,368 -332	-1%	-$21.9K	0.93%	37
2015 Q1	$1.59M	Buy	+24,700	New	+$1.55M	0.82%	57

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Kingfisher Capital's BMY Position: Q4 2023 in Review

Kingfisher Capital sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 3,702 shares — an estimated $215K sold.

Kingfisher Capital first reported a position in BMY in Q1 2015 and held it in 12 quarters. The position peaked at $1.83M in Q2 2016. 2,365 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Kingfisher Capital reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Kingfisher Capital sold 3,702 Bristol-Myers Squibb shares in Q4 2023, an estimated $215K.
Kingfisher Capital first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 12 quarters.
Kingfisher Capital's Bristol-Myers Squibb position peaked at $1.83M in Q2 2016.
2,365 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Kingfisher Capital's 13F filing for Q4 2023, filed 14 Feb 2024.